Path: utzoo!attcan!uunet!lll-winken!brutus.cs.uiuc.edu!apple!usc!henry.jpl.nasa.gov!elroy.jpl.nasa.gov!ucla-cs!asuvax!stjhmc!f98.n125.z1.fidonet.org!Dave.Giunti@ncar.UCAR.EDU From: asuvax!stjhmc!f98.n125.z1.fidonet.org!Dave.Giunti@ncar.UCAR.EDU (Dave Giunti) Newsgroups: sci.med.aids Subject: Re: Drugs Message-ID: <26681@shemp.CS.UCLA.EDU> Date: 23 Aug 89 19:01:14 GMT Sender: news@CS.UCLA.EDU Organization: FidoNet node 1:125/98 - Has anyone heard about GLQ223 or CD4-lgG? I believe GLQ223 is also called Compound Q. This drug is currently under close study. CD4 has been studied for several years, and there is quite a bit of lit. on it... You could check through recent issues of Aids Treatment News [ATN] for details. > The Oct hustler had a article about both of these drugs, > and saying > that a chure may be around the corner.GLQ223 will hout > out and kill only the infected or damagted cells. In the > test tube, GLQ223 destorys only cells with the HIV virus, > leaving healthy cells alone. If anyone wants > I will type the article in as a ASCII file and u/l it. If you can get them to give you a copyright release to post their article in electronic form for distribution around the world to people that would not be able to buy Hustler on the news-stand, I'm sure it would be interesting... Dave -- Uucp: ...{gatech,ames,rutgers}!ncar!noao!asuvax!stjhmc!125!98!Dave.Giunti Internet: Dave.Giunti@f98.n125.z1.fidonet.org